Kenneth Frazier - Wikipedia
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).
Kenneth C. Frazier's Biography - The HistoryMakers
2012年8月2日 · Pharmaceutical executive, lawyer, and corporate general counsel Kenneth C. Frazier was born on December 17, 1954 in Philadelphia, Pennsylvania to janitor and former sharecropper Otis Tindley Frazier and homemaker Clara Elizabeth Frazier.
Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert …
2021年2月4日 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.
Robert M. Davis to Succeed Kenneth C. Frazier as Chairman of …
2022年10月26日 · He will succeed Kenneth C. Frazier, who plans to retire on Nov. 30, 2022, after a long-tenured career at Merck that began in 1992. Frazier led the company for 10 years as president and chief executive officer, from 2011 through 2021.
Kenneth C. Frazier (1954- ) - Blackpast
2014年3月21日 · Kenneth C. Frazier is the first African American President of Merck & Co., a major pharmaceutical corporation. Frazier was elected by the Board of Directors to be the next CEO on May 1, 2010, and assumed the post on January 1, 2011.
Kenneth C. Frazier | Constitution Center
Kenneth C. Frazier is Executive Chairman of Merck’s board of directors, after stepping down as CEO on July 1, 2021. He previously served as President and Chief Executive Officer since 2011. Prior to joining Merck in 1992, Mr. Frazier was a partner with the Philadelphia law firm of Drinker Biddle & Reath.
Kenneth C. Frazier is the Executive Chairman of MSD’s board of directors, a role he began in July 2021, following his retirement from a decade-long tenure as MSD’s President and Chief Executive Officer.
Merck’s Longtime CEO Ken Frazier Steps Down After Nearly
2021年2月4日 · Merck Chief Executive Officer Kenneth C. Frazier is stepping down from his role atop the helm of the pharma giant on June 30 after nearly 30 years with the company. He will be replaced by Robert M. Davis, Merck’s chief financial officer and head of global services.
Kenneth C. Frazier has served as the Chairman of the Board and Chief Executive Officer of MSD since 2011. Under Ken’s leadership, MSD is delivering innovative lifesaving medicines and vaccines as well as long-term and sustainable value to its multiple stakeholders.
What You Should Know About Ken Frazier, The CEO Who Just Quit ... - Forbes
2017年8月14日 · Kenneth C. Frazier, the chairman and chief executive of the U.S. drug maker Merck, resigned from President Donald Trump’s American Manufacturing Council on Monday morning, saying in a statement...